NEW YORK (GenomeWeb News) – Thermo Fisher Scientific yesterday said that Belgian molecular diagnostics firm Pronota is using the firm’s new HeavyPeptide FasTrack service, which provides a selection of crude heavy peptides for more rapid development of protein assays.
Thermo Fisher said that the crude peptides are used in mass spectrometry setup to identify the best proteotypic peptides. After customers identify their candidates, Thermo Fisher uses retained crude stock to rapidly produce the final purified heavy peptides as HeavyPeptide Aqua Kits.
Pronota uses its own MASStermind mass spec platform for biomarker validation and is developing tests based on the protein biomarkers. The firm also provides pharmaceutical partners with biomarker discovery and validation services.
“In the past, we had to wait four to five weeks for purified peptides,” said Katleen Verleysen, vice president of operations and technology development at Pronota. “Now, we get the crude peptides in about 10 days and can start building our assays right away.”
Terms of the alliance were not disclosed.